Explore more publications!
California Health Watch
Got News to Share?

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 3, 2025

Secuvy Expands Deployment Options to Azure, GCP, and On-Premise, Granting Customers Unprecedented Data Control
November 3, 2025

Secuvy Expands Deployment Options to Azure, GCP, and On-Premise, Granting Customers Unprecedented Data Control

Indeterminate EIN Presswire
Divine Spine Offers Unexpected Support During Cold and Flu Season with Gentle, Technology-Driven Spinal Care
November 3, 2025

Divine Spine Offers Unexpected Support During Cold and Flu Season with Gentle, Technology-Driven Spinal Care

Indeterminate EIN Presswire
CallMyDoc™ Revolutionizes Healthcare Communication with AI-Powered Front Desk Automation
November 3, 2025

CallMyDoc™ Revolutionizes Healthcare Communication with AI-Powered Front Desk Automation

Indeterminate EIN Presswire
Hanabusa IVF Awarded Best Practice Recognition for Cryopreservation Excellence by Kitazato IVF
November 3, 2025

Hanabusa IVF Awarded Best Practice Recognition for Cryopreservation Excellence by Kitazato IVF

Indeterminate EIN Presswire
SideBar: Optimism in Action Welcomes Monica Ojcius, Director of Strategic Development at Community Hospice, Inc.
November 3, 2025

SideBar: Optimism in Action Welcomes Monica Ojcius, Director of Strategic Development at Community Hospice, Inc.

Indeterminate EIN Presswire
OnsiteGene Introduces XDive™ — The Future of 5-Minute PCR Testing
November 3, 2025

OnsiteGene Introduces XDive™ — The Future of 5-Minute PCR Testing

Indeterminate EIN Presswire
CureMetrix joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
November 3, 2025

CureMetrix joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

Indeterminate EIN Presswire
Proximal Contact, LLC Launches 11th Annual Dental Podcast Voting Contest
November 3, 2025

Proximal Contact, LLC Launches 11th Annual Dental Podcast Voting Contest

Indeterminate EIN Presswire
Better U Expands Access to Psychedelic Therapy with Launch of National Therapist Partner Program
November 3, 2025

Better U Expands Access to Psychedelic Therapy with Launch of National Therapist Partner Program

Indeterminate EIN Presswire
ancora Software Reports Strong Q3 Results with 42% Year-to-Date Growth, 78 New Customers and Expansion into Tampa, FL
November 3, 2025

ancora Software Reports Strong Q3 Results with 42% Year-to-Date Growth, 78 New Customers and Expansion into Tampa, FL

Indeterminate EIN Presswire
CurrentWare v11.0.2 Launches with Smarter Workforce Analytics, Seamless Integrations, Advanced Security & Monitoring
November 3, 2025

CurrentWare v11.0.2 Launches with Smarter Workforce Analytics, Seamless Integrations, Advanced Security & Monitoring

Indeterminate EIN Presswire
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
November 3, 2025

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease
November 3, 2025

FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Flo Health and Dr. Sameena Rahman Address Perimenopause and Its Workplace Impact with YourUpdateTV
November 3, 2025

Flo Health and Dr. Sameena Rahman Address Perimenopause and Its Workplace Impact with YourUpdateTV

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
November 3, 2025

Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

Indeterminate GlobeNewswire
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
November 3, 2025

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer

Indeterminate GlobeNewswire
DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial
November 3, 2025

DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions